Discussion on role of enterprises in re-evaluation of traditional Chinese medicine injection

Zhongguo Zhongyao Zazhi

Volumn 34, Issue 10, 2009, Pages 1326-1328

  Li, Xinling ^a   Song, Ligang ^b   Liu, Ying ^b   Bo, Yanjun ^c  

^a Center for Drug Reevaluation State Food and Drug Administration   (China)

^b Center for Adverse Drug Reaction Monitoring of Tianjin   (China)

^c XIYUAN HOSPITAL   (China)

Author keywords

Re evaluation; Traditional Chinese medicine injection

Indexed keywords

CHINESE DRUG;

CHINESE MEDICINE; DRUG FORMULATION; DRUG INDUSTRY; DRUG QUALITY; DRUG RESEARCH; DRUG SCREENING; INJECTION; PROCESS TECHNOLOGY; REVIEW;

BIOMEDICAL RESEARCH; DRUG EVALUATION; DRUG TOXICITY; DRUGS, CHINESE HERBAL; HUMANS; LONGITUDINAL STUDIES; MEDICINE, CHINESE TRADITIONAL; PUBLIC SECTOR; RESEARCH DESIGN;

EID: 68449084731     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)